Gut and liver

Keyphrases

Publications

volume 17, number 1, 2023

Seong Hee Kang, Eileen L Yoon
Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis. Gut and liver 17 (1) (2023)
Namki Hong
High Fatty Liver Index and Fracture Risk: Clinical Implications. Gut and liver 17 (1) (2023)
Dong Uk Kim
Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma? Gut and liver 17 (1) (2023)
Bong Eun Lee
Clinical Relevance of Helicobacter pylori Coinfection in Ebstein-Barr Virus-Associated Gastric Carcinoma. Gut and liver 17 (1) (2023)
Sung Eun Kim
Changes in Metabolic Parameters by Helicobacter pylori Eradication According to Sex Differences. Gut and liver 17 (1) (2023)
Dong Uk Kim
Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma? Gut and liver 17 (1) (2023)
Namki Hong
High Fatty Liver Index and Fracture Risk: Clinical Implications. Gut and liver 17 (1) (2023)
Sung Eun Kim
Changes in Metabolic Parameters by Helicobacter pylori Eradication According to Sex Differences. Gut and liver 17 (1) (2023)
Seong Hee Kang, Eileen L Yoon
Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis. Gut and liver 17 (1) (2023)
Namki Hong
High Fatty Liver Index and Fracture Risk: Clinical Implications. Gut and liver 17 (1) (2023)
Sung Eun Kim
Changes in Metabolic Parameters by Helicobacter pylori Eradication According to Sex Differences. Gut and liver 17 (1) (2023)
Bong Eun Lee
Clinical Relevance of Helicobacter pylori Coinfection in Ebstein-Barr Virus-Associated Gastric Carcinoma. Gut and liver 17 (1) (2023)
Bong Eun Lee
Clinical Relevance of Helicobacter pylori Coinfection in Ebstein-Barr Virus-Associated Gastric Carcinoma. Gut and liver 17 (1) (2023)
Seong Hee Kang, Eileen L Yoon
Sarcopenic Obesity, the Possible Culprit for Nonalcoholic Fatty Liver Disease or Fibrosis. Gut and liver 17 (1) (2023)
Dong Uk Kim
Are the Immunohistochemistry-Based Biomarkers Helpful for Predicting Prognosis in Patients with Surgically Resected Cholangiocarcinoma? Gut and liver 17 (1) (2023)

volume 17, number 2, 2023

volume 17, number 3, 2023

volume 17, number 4, 2023

volume 17, number 5, 2023

Hyo-Joon Yang, Young-Il Kim, Ji Yong Ahn, Kee Don Choi, Sang Gyun Kim, Seong Woo Jeon, Jie-Hyun Kim, Sung Kwan Shin, Hyuk Lee, Wan Sik Lee, Gwang Ha Kim, Jae Myung Park, Woon Geon Shin, Il Ju Choi
Corrigendum to: External Validation of the eCura System for Undifferentiated-Type Early Gastric Cancer with Noncurative Endoscopic Resection. Gut and liver 17 (5) (2023)
Won-Mook Choi
Pretransplant Frailty on Postoperative Morbidity and Mortality after Liver Transplantation: Bystander or Upstander? Gut and liver 17 (5) (2023)
Kyong Joo Lee, Se Woo Park
Evaluating the Self-Expandable Metal Stents Placement in Malignant Biliary Obstruction: A Deeper Dive. Gut and liver 17 (5) (2023)
Hyun Ho Choi
Is Tegoprazan-Based Triple Therapy Effective in Regions with High Rates of Clarithromycin Resistance? Gut and liver 17 (5) (2023)
Jung Wook Kim, Albert C Kim
Should All Undifferentiated Early Gastric Cancer Patients Undergoing Noncurative Endoscopic Resection Be Sent to the Operating Room? Gut and liver 17 (5) (2023)

volume 17, number 6, 2023